Screener
Regeneron Pharmaceuticals REGN Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's net debt?
- Regeneron Pharmaceuticals (REGN) reported net debt of $240.6M in Q2 2026.
- How has Regeneron Pharmaceuticals's net debt changed year-over-year?
- Regeneron Pharmaceuticals's net debt decreased by 65.1% year-over-year, from $689.5M to $240.6M.
- What is the long-term trend for Regeneron Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's net debt has grown at a -20.9% compound annual growth rate (CAGR), from $488.4M to -$151M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Regeneron Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude